# To Determine the Effect of Forlax® Treatment in Children With Chronic Constipation Who May Also Suffer From Soiling/ Faecal Incontinence.

> **NCT00255372** · PHASE3 · COMPLETED · sponsor: **Ipsen** · enrollment: 88 (actual)

## Conditions studied

- Chronic Constipation

## Interventions

- **DRUG:** PEG 4000 (Forlax®)
- **DRUG:** Lactulose active and Lactulose placebo

## Key facts

- **NCT ID:** NCT00255372
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2008-05-20
- **Final completion:** 2008-05-20
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2020-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00255372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00255372, "To Determine the Effect of Forlax® Treatment in Children With Chronic Constipation Who May Also Suffer From Soiling/ Faecal Incontinence.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00255372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*